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Abstract
The preantral-early antral follicle transition is the penultimate stage of follicular development in
terms of gonadotropin dependence and follicle destiny (growth versus atresia). Follicular growth
during this period is tightly regulated by oocyte-granulosa-theca cell interactions. Formation of the
theca cell layer is a key event that occurs during this transitional stage. Granulosal factor(s)
stimulates the recruitment of theca cells from cortical stromal cells, while oocyte-derived growth
differentiation factor-9 (GDF-9) is involved in the differentiation of theca cells during this early
stage of follicular development. The preantral to early antral transition is most susceptible to
follicular atresia. GDF-9 promotes follicular survival and growth during transition from preantral
stage to early antral stage by suppressing granulosa cell apoptosis and follicular atresia. GDF-9 also
enhances preantral follicle growth by up-regulating theca cell androgen production. Thecal factor(s)
promotes granulosa cell proliferation and suppress granulosa cell apoptosis. Understanding the
intraovarian mechanisms in the regulation of follicular growth and atresia during this stage may be
of clinical significance in the selection of the best quality germ cells for assisted reproduction. In
addition, since certain ovarian dysfunctions, such as polycystic ovarian syndrome and gonadotropin
poor-responsiveness, are consequences of dysregulated follicle growth at this transitional stage,
understanding the molecular and cellular mechanisms in the control of follicular development
during the preantral-early antral transition may provide important insight into the pathophysiology
and rational treatment of these conditions.
Introduction
The ovarian follicle, consisting of an oocyte surrounded by
granulosa and theca cells, represents the basic functional unit
of the ovary. Follicular growth can be classified into three
phases according to their developmental stage and gonado-
tropin dependence [1-3] (Fig. 1): (1) follicular growth
through primordial, primary, and secondary stages (gonado-
tropin-independent phase), (2) transition from preantral to
early antral stage (gonadotropin-responsive phase), and (3)
continual growth beyond the early antral stage (gonadotro-
pin-dependent phase), which includes follicle recruitment,
selection, and ovulation [4]. In the second (gonadotropin-
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responsive) phase, growth of the follicles is primarily con-
trolled by intraovarian regulators (e.g., growth factors,
cytokines, and gonadal steroids) and does not require gona-
dotropins for growth [5,6], although it is also stimulated by
the presence of FSH [1,7,8].
The transition of the follicle from the preantral to early
antral stage is the "penultimate" stage of development in
terms of gonadotropin dependence and follicle destiny
(growth versus atresia) [9] (Fig. 1). Follicles selected for
further development are thought to receive precise gona-
dotropic and intra-ovarian regulatory signals for survival,
whereas follicular atresia is a consequence of inadequate
growth support [10]. As the preantral-early antral transi-
tion is most susceptible to follicular atresia [1,11], under-
standing the intraovarian mechanisms in the regulation of
follicular growth and atresia during this stage may be of
clinical significance in providing germ cells for assisted
reproduction. Since ovarian dysfunctions, such as poly-
cystic ovarian syndrome (PCOS) and gonadotropin poor-
responsiveness, are consequences of this transitional
stage-specific dysregulated follicle growth [3], under-
standing the molecular and cellular mechanisms in the
control of follicular development during the preantral-
early antral transition may provide important insight into
the pathophysiology of these conditions. This review will
focus on recent progress that has been made in under-
standing the importance of intraovarian cell-cell interac-
tions during follicular development from preantral to
early antral stage.
Formation of the theca cell layer
The role of theca cells in follicular function has received
less attention compared with intensive investigation into
the role of granulosa cells [12]. Nevertheless, the appear-
ance of a theca cell layer at the preantral stage is an impor-
tant physiological event for early follicular development,
as evidenced by: 1) the concurrence of the organization of
the theca cell layer and the increased follicular growth and
steroidogenic response to gonadotropins [13,14]; 2)
increased structural support by the theca cell layer and
blood supply containing ovarian regulators for the devel-
oping follicle [15,16]; and 3) increased thecal aromatiza-
ble androgen production for granulosa cell estrogen
biosynthesis and enhanced early follicular growth by
androgenic products of the theca cell [17-21].
Granulosa-stromal (pretheca) cell interaction
The origin of theca cells has been a long-standing research
interest and whether the cortical or medullary stromal
cells are thecal stem cells remains an unanswered ques-
tion. Our recent studies with a bovine co-culture model
[22,23] indicates that cortical but not medullary stromal
cells are actively transformed into theca cells by the pres-
ence of granulosa cells, a process associated with
increased LH receptor (LHR) mRNA expression and
androstenedione production [24]. These findings suggest
that granulosa cells play a decisive role in the differentia-
tion of cortical stromal cells into LH-responsive steroidog-
enically active theca cells by the secretion and action of a
soluble factor(s). In support of this theory, an array of
The transition of the follicle from the preantral to early antral stage is the "penultimate" stage of development in terms of gona- dotropin (Gn) dependence and follicle destiny (growth versus atresia) Figure 1
The transition of the follicle from the preantral to early antral stage is the "penultimate" stage of development 
in terms of gonadotropin (Gn) dependence and follicle destiny (growth versus atresia).
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paracrine factors from granulosa cells governing theca cell
differentiation have been reported in humans [25].
Huang et al. reported that the combination of two granu-
losa cell-produced peptides, i.e. insulin-like growth factor-
I (IGF-I) and kit ligand (KL), increased gene expression for
androgenic factors and androgen production in rat theca-
interstitial cells [26]. Using the bovine ovarian organ cul-
ture model, Parrott and Skinner also reported that KL
stimulated ovarian stromal cell proliferation, whereas it
had no effect on androgen production [27]. Theca cells
maintain epithelial-like appearance and androgenic
capacity when co-cultured with granulosa cells, but
become fibroblastic and produce less androgen when cul-
tured alone [22], suggesting that the presence of granu-
losal factor(s) is indispensable for theca cells to sustain
their morphology and function.
Oocyte-theca cell interaction
Oocyte-somatic cell interaction plays a critical role in fol-
liculogenesis, including activation of resting follicles,
early growth, and terminal differentiation [28-31].
Growth differentiation factor-9 (GDF-9) is an oocyte-
derived factor and a member of the TGF-β superfamily,
which includes TGF-β, activin, and bone morphogenetic
proteins (BMPs) [32,33]. Ovaries from GDF-9 null mice
exhibit a developmental block at the primary follicle
stage, which is characterized by failed theca cell layer for-
mation in early follicles [34]. These observations raise the
possibility that GDF-9 also stimulates theca cell recruit-
ment, proliferation and differentiation, and induces the
formation of theca cell layer during this early stage of the
follicular development. Nevertheless, GDF-9 is believed
to be more important for the differentiation than the
recruitment of theca cells, since the double-mutant (GDF-
9 and inhibin α) mouse exhibits preantral follicles with
theca cells having typical morphology but undetectable
selective thecal markers, CYP17A1 and LH receptor [35].
GDF-9 treatment increases androgen production in cul-
tured rat theca-interstitial cells [36] and promotes murine
ovarian expression of the specific theca cell marker
CYP17A1 [34]. GDF-9 increases theca cell number and
DNA synthesis in theca cells of small bovine follicles [37].
We recently indicated that GDF-9 augments androgen
production and CYP17A1 mRNA expression in rat prean-
tral follicles, whereas down-regulation of GDF-9 by intra-
oocyte injection of GDF-9 Morpholino antisense oligos
suppressed these responses, indicating that GDF-9 is
important in theca cell differentiation during preantral-
early antral transition [38].
Follicular growth and atresia during the preantral-early 
antral transition
In mammals, a single or small number of germ cell(s) will
ovulate during an ovarian cycle, whereas most follicles
undergo atresia by follicle cell apoptosis [1,3,15], a selec-
tion process that ensures the release of only the healthiest
Follicular growth during the preantral/early antral transition is tightly regulated by intra-ovarian oocyte-granulosa-theca cell  interactions Figure 2
Follicular growth during the preantral/early antral transition is tightly regulated by intra-ovarian oocyte-gran-
ulosa-theca cell interactions.
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and most viable oocytes [39,40]. Cell apoptosis is trig-
gered by activation of a series of cysteine aspartate-specific
proteases (caspases), which include initiator caspases (e.g.
caspase-8 and -9) and effector caspases (e.g. caspase-3).
Although apoptosis can occur at all stages of follicular
development, the early antral follicles (diameter: 200–
400 μm in rats, 2–5 mm in human) are most susceptible
to atreatogenic signals [1,11,41]. In contrast, minimal
atresia or granulosa cell apoptosis is evident in preantral
and the smallest antral follicles (diameter: <200 μm in
rats, <2 mm in human) [15,42]. Accordingly, the preant-
ral to early antral transition is the penultimate stage of
development in terms of gonadotropin dependence and
follicle destiny (survival/growth vs. atresia) [9]. Follicular
growth and atresia during this transitional stage is mainly
regulated by intrafollicular regulators, such as growth fac-
tors, cytokines, and steroids.
Oocyte-granulosa cell interaction
Deletion of GDF-9 in the oocyte results in decreased gran-
ulosa cell proliferation, abnormal oocyte growth, and fail-
ure of follicles to develop past the primary stage [43],
demonstrating the importance of this growth factor in
early follicular development. GDF-9 stimulates rat granu-
losa cell proliferation, cumulus cell expansion, and prean-
tral follicle growth in vitro [44]. We have recently
demonstrated that GDF-9 down-regulation attenuates
both basal and FSH-induced follicular growth in vitro,
while the addition of recombinant GDF-9 enhances basal
and FSH-induced follicular growth in rat [9]. In addition,
down-regulation of GDF-9 content increases caspase-3
activation and granulosa cell apoptosis [9]. GDF-9 was
sufficient to suppress ceramide-induced apoptosis in pri-
mary granulosa cells from early antral, but not large/preo-
vulatory follicles [9], suggesting that GDF-9 is an
important granulosa cell survival factor during the prean-
tral to early antral transition, but may play a lesser role in
follicle survival past antrum formation. GDF-9 also pro-
motes development and survival of human early follicles
in organ culture [45]. There may be considerable crosstalk
between GDF-9 and FSH during the preantral-early antral
transition, as GDF-9 is required to maintain FSH receptor
expression in the preantral follicles [9], and GDF-9 recep-
tors (BMPRII and ALK-5) are up-regulated by co-treatment
of estrogen and FSH [46]. Although bone morphogenic
protein-15 (BMP-15), another oocyte-specific member of
the TGF-β superfamily, is also an important regulator of
ovarian function [33], whether its action in granulosa
cells is anti-apoptotic during this transitional stage and
important in protecting the preantral follicles from under-
going atresia remains unknown.
Oocyte-theca cell interaction
Ovarian androgens are produced by theca cells, and act via
receptors (AR) localized to granulosa cells, stromal cells,
and oocytes [47]. Inactivation of AR in female mice results
in premature ovarian failure, indicating that normal fol-
liculogenesis requires AR-mediated androgen action
[48,49]. AR expression is highest in granulosa cells of rat
small preantral and early antral follicles [50], raising the
possibility that androgens are important paracrine regula-
tors of follicular growth during preantral to early antral
transition. Although androgens have long been impli-
cated as an inhibitor of antral follicular development
[51,52], recent evidence suggests that the effect of andro-
gens on follicular growth is dependent on the stage of fol-
licular development and that androgens also have a
growth promoting role in early folliculogenesis. Adminis-
tration of androgens to adult rhesus monkeys significantly
increased the number of preantral and small antral folli-
cles as well as granulosa and theca cell proliferation [17].
In vitro studies have shown that androgens stimulate pre-
antral follicle growth and granulosa cell mitosis in mice
[19], the transition of primary follicles to secondary folli-
cles in cattle [53], and follicular survival in human [54].
We have recently shown that oocyte-derived GDF-9
enhances rat preantral follicle growth, and augments
androgen production and CYP17A1 mRNA expression in
the preantral follicles, whereas down-regulation of GDF-9
suppressed these responses [38]. The specific AR antago-
nist flutamide suppressed GDF-9-induced preantral folli-
cle growth in vitro [38]. The non-aromatizable androgen
DHT, but not estradiol, rescued the follicular growth
arrest by GDF-9 down-regulation [38], indicating that
androgens exert a direct stimulatory action on the follicu-
lar development, especially during the preantral-early
antral stage transition. These results suggest that GDF-9
promotes rat preantral follicle growth by up-regulating
theca cell androgen production.
Theca-granulosa cell interaction
Evidence indicates that steroidal and nonsteroidal factors
produced by granulosa and theca cells influence prolifer-
ation and differentiation of both cell types on opposite
sides of a basement membrane during folliculogenesis
[1,7,15,55-58]. LH receptors are found exclusively on
theca cells and FSH receptors exclusively on granulosa
cells during preantral follicle development. LH stimulates
theca cell androgen and growth factor production, while
FSH induces aromatase expression and increases the con-
version of theca cell androgen to estrogen (two-cell two-
gonadotropin theory [59]). Although growth beyond the
small antral follicle is characterized by increased aro-
matase activity and follicular estrogen production, the
aromatase activity before the small antral stage is limited
[47], suggesting that androgen plays a more important
role than estrogen during the preantral to early antral tran-
sition. It has been reported that androgens stimulate pre-
antral follicle growth and granulosa cell mitosis [17,19].Journal of Ovarian Research 2009, 2:9 http://www.ovarianresearch.com/content/2/1/9
Page 5 of 7
(page number not for citation purposes)
Androgens also enhance FSH action in the follicles by
increasing FSH receptor expression, FSH-induced granu-
losa cell aromatase activity and proliferation, and follicu-
lar growth [18,47,60,61]. Although we have shown that
GDF-9 is required for the expression of FSH receptor in rat
preantral follicles [9], whether this response is modulated
through thecal androgen actions awaits further investiga-
tion. Although it has been demonstrated that LH stimu-
lates follicular maturation [62,63] and induces follicular
atresia [64], recent studies suggest that LH is also a stimu-
lant for early stages of follicular growth [12,65,66].
Our previous studies suggest that theca cell-derived solu-
ble growth factors promote granulosa cell proliferation
[22] and suppress granulosa cell apoptosis [12] in early,
but not large, antral follicles. Although the nature of the
theca-granulosa cell interaction remains to be deter-
mined, recent studies also suggest the importance of this
interaction in the regulation of apoptosis of granulosa
cells. Epidermal growth factor (EGF), TGF-α, keratinocyte
growth factor (KGF), hepatocyte growth factor (HGF),
and BMP-7 appear to be potential physiological inhibitors
of apoptotic cell death in the ovary [27,67-71]. These
growth factors produced by theca cells might be one of the
factors that decreased the incidence of apoptosis in gran-
ulosa cells during the preantral/early antral transition.
Conclusion
The preantral to early antral transition is the penultimate
stage of follicular development in terms of gonadotropin
dependence and follicle destiny (growth versus atresia).
Follicular growth during the preantral-early antral transi-
tion is tightly regulated by intra-ovarian oocyte-granu-
losa-theca cell interactions (Fig. 2). Formation of the theca
cell layer is a key event that occurs during this transitional
stage. Granulosal factor(s) appears to stimulate the
recruitment of theca cells from cortical stromal cells, while
oocyte-derived GDF-9 is involved in the differentiation of
theca cells during this early stage of follicular develop-
ment. The preantral to early antral transition is most sus-
ceptible to atreatogenic factors. GDF-9 also promotes
follicular survival and growth during the preantral to early
antral transition by suppressing granulosa cell apoptosis
and follicular atresia. GDF-9 enhances preantral follicle
growth by up-regulating theca cell androgen production.
Thecal factor(s) also promote granulosa cell proliferation
and suppress granulosa cell apoptosis. The challenge
ahead is not only understand the precise nature of these
interactions, but also how they interact in the regulation
of follicle destiny, and how dysregulation in these interac-
tions may lead to ovarian pathology such as PCOS and
gonadotropin poor-responsiveness. In addition, identifi-
cation of the factor(s) that promote follicle growth from
the preantral stage to small antral stage may provide
important information for the identification of intra-fol-
licular biomarkers for the selection of healthy oocytes and
embryos in assisted reproduction.
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